The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.86
Bid: 27.90
Ask: 27.94
Change: -0.82 (-2.86%)
Spread: 0.04 (0.143%)
Open: 28.50
High: 28.82
Low: 27.86
Prev. Close: 28.68
HMSO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Hammerson PLC

15 Mar 2018 12:28

Norges Bank - Form 8.3 - Hammerson PLC

Norges Bank - Form 8.3 - Hammerson PLC

PR Newswire

London, March 15

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Norges Bank
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeHammerson PLC
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:N/A
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosureDealing Disclosure 14/03/2018
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”Yes Intu Properties plc

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:25p ordinary
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:15,578,0631.96
(2) Cash-settled derivatives:
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
TOTAL:15,578,063*1.96

*Norges Bank does not have discretion regarding dealing and offer acceptance decisions in respect of 1,248,259 shares that are included in the total above.

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
25p ordinaryPurchase73,221 4.589

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:15/03/2018
Contact name:Philippe Chiaroni
Telephone number:+4724073297

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
23rd Mar 20211:30 pmRNSHolding(s) in Company
23rd Mar 20218:30 amRNSCurrency Conversion & Scrip Reference Share Price
18th Mar 202110:30 amRNSHolding(s) in Company
17th Mar 20211:45 pmRNSDirector/PDMR Shareholding
17th Mar 202110:15 amRNSHolding(s) in Company
16th Mar 20211:15 pmRNSHolding(s) in Company
15th Mar 202111:15 amRNSHolding(s) in Company
12th Mar 20217:01 amRNSDividend Declaration
12th Mar 20217:00 amRNSBoard Changes
12th Mar 20217:00 amRNSFinal Results
11th Mar 20213:30 pmRNSHolding(s) in Company
11th Mar 20219:30 amRNSHolding(s) in Company
10th Mar 202110:15 amRNSHolding(s) in Company
2nd Mar 202110:15 amRNSHolding(s) in Company
1st Mar 202110:15 amRNSHolding(s) in Company
26th Feb 202110:15 amRNSHolding(s) in Company
23rd Feb 20219:30 amRNSHolding(s) in Company
22nd Feb 202111:00 amRNSHolding(s) in Company
19th Feb 202111:00 amRNSHolding(s) in Company
16th Feb 20219:30 amRNSHolding(s) in Company
15th Feb 202111:30 amRNSNotification of 2020 Full Year Results
29th Jan 20213:30 pmRNSDirector/PDMR Shareholding
19th Jan 20217:00 amRNSOperational and Rent Collection Update
15th Jan 20217:00 amRNSBoard Change
12th Jan 20213:30 pmRNSHolding(s) in Company
8th Jan 202110:30 amRNSHome Member State
8th Jan 20219:30 amRNSHolding(s) in Company
6th Jan 20213:45 pmRNSHolding(s) in Company
24th Dec 20208:30 amRNSNotification of Transactions of Directors /PDMRs
23rd Dec 20208:01 amRNSAdmission to the official list of Euronext Dublin
22nd Dec 20209:30 amRNSHolding(s) in Company
21st Dec 20207:00 amRNSAppointment of new Non-Executive Director
18th Dec 20209:00 amRNSTotal Voting Rights
18th Dec 20207:00 amRNSIntention to seek admission to Euronext Dublin
16th Dec 202012:00 pmRNSInterim 2020 Dividend/Enhanced Script Correction
14th Dec 202010:30 amRNSHolding(s) in Company
8th Dec 20201:15 pmRNSInterim Dividend and Enhanced Scrip Alternative
4th Dec 202012:15 pmRNSResults of the General Meeting
2nd Dec 20209:30 amRNSHolding(s) in Company
30th Nov 20209:30 amRNSBlock listing Interim Review
25th Nov 202010:30 amRNSHolding(s) in Company
19th Nov 20209:00 amRNSCash Fractions for the Enhanced Scrip Dividend
18th Nov 20207:20 amRNSScrip Ratio Announcement
17th Nov 20208:00 amRNSCurrency Conversion & Scrip Reference Share Price
16th Nov 202010:00 amRNSHolding(s) in Company
11th Nov 20207:00 amRNSInterim Dividend and Enhanced Scrip Alternative
4th Nov 20203:30 pmRNSDirector/PDMR Shareholding
3rd Nov 202011:00 amRNSDirector/PDMR Shareholding
2nd Nov 20207:00 amRNSCompletion of VIA Disposal
29th Oct 202011:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.